1. Companies

  2. Alexion Pharmaceuticals

Alexion Pharmaceuticals

Alexion Pharmaceuticals

Alexion Pharmaceuticals, Inc (NASDAQ: ALXN) | World Leader in Treatments for Patients with Devastating and Rare Diseases.
Launch date
Employees
5001-10000 people
Market cap
-
Enterprise valuation
€35.5b (Public information from Dec 2020)
Boston Massachusetts (HQ)
https://alexion.com/
https://twitter.com/alexionpharmahttps://www.linkedin.com/company/alexion-pharmaceuticals

Financials

Estimates*

Edit
Revenues, earnings & profits over time
USD2016201720182019202020212022
Revenues-3.6b4.1b5.0b6.1b6.6b7.2b
% growth--16 %21 %22 %10 %8 %
EBITDA-2.1b2.6b3.2b3.7b4.0b4.0b
% EBITDA margin-59 %63 %63 %61 %60 %56 %
Profit-443m77.0m2.4b603m2.5b2.8b
% profit margin-12 %2 %48 %10 %38 %38 %
R&D budget790m805m702m868m---
R&D % of revenue-23 %17 %17 %---

Source: Dealroom estimates

    • Edit
DateInvestorsAmountRound
-

N/A

-

N/A

Early VC
N/A

N/A

IPO
N/A

RSD3.5m

Seed

$39.0b

Valuation: $39.0b

7.8x EV/LTM Revenues

12.3x EV/LTM EBITDA

Acquisition
Total Funding€35.0k

Related Content

Recent News about Alexion Pharmaceuticals

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Alexion Pharmaceuticals

Edit
Moderna Therapeutics
Moderna Therapeutics
exited
Synageva BioPharma
Synageva BioPharma
ACQUISITION by Alexion Pharmaceuticals May 2015
Taligen Therapeutics
Taligen Therapeutics
ACQUISITION by Alexion Pharmaceuticals Jan 2011
Enobia Pharma
Enobia Pharma
ACQUISITION by Alexion Pharmaceuticals Dec 2011
Achillion Pharmaceuticals
Achillion Pharmaceuticals
ACQUISITION by Alexion Pharmaceuticals Oct 2019
Portola Pharmaceuticals
Portola Pharmaceuticals
ACQUISITION by Alexion Pharmaceuticals May 2020
Wilson Therapeutics
Wilson Therapeutics
ACQUISITION by Alexion Pharmaceuticals Apr 2018
LogicBio Therapeutics
LogicBio Therapeutics
ACQUISITION by Alexion Pharmaceuticals Oct 2022